pharma-company /Medicinal products /Active ingredients

Rx · PZN 18600893, 18600835, 18600864

RANOLAZIN TAD 500 mg prolonged-release tablets

German trade nameRANOLAZIN TAD 500 mg Retardtabletten

Active ingredientRanolazineSubstance (DE)RanolazinPharmaceutical formProlonged-release tablets

Consistently available

9.6

out of 10

0510

Pharma availability index · 30 days · as of 01.08.2026


Storage temperature and transport temperature

Ambient max. 25 °C

Average purchase price (B2B)

~ €45

We deliver data-driven insights into pharmaceutical price levels and pricing structures across European markets, enabling Most Favoured Nation (MFN) assessments, international price benchmarking, and strategic market access analyses.

RANOLAZIN TAD 500 mg prolonged-release tablets is consistently available through wholesale. We are happy to review your purchase price and advise you on it.

Review purchasing terms

RANOLAZIN TAD 500 mg prolonged-release tablets contains the active ingredient Ranolazine (German Ranolazin) and comes as Prolonged-release tablets. 3 pack sizes of this product are recorded. Availability in German wholesale varied over the past 30 days depending on pack size: from index 0.0 to 9.6 out of 10. The best-available pack was consistently available.


Pack sizes · 3 PZN

PZNIndex 7 dIndex 30 d Highest known purchase price
186008649.49.6~ €50
186008358.28.3~ €39
186008930.00.0N/A

We are happy to advise you on sources of supply, purchase prices and procurement optimisation for your pharmaceutical wholesale business or your pharmacy.

Get in touch

The pharma availability index is averaged from the data available to us. Purchase prices are rounded approximations in euros. The average purchase price was calculated across 2 of 3 PZNs.